Introduction
Hyaluronan is a high molecular weight linear glycosaminoglycan of alternating glucuronic acid and Nacetylglucosamine residues and is found in the extracellular matrix, especially of connective tissues such as dermis 1) . Hyaluronan has several physiochemical and biologic functions, such as space filling, lubrication, cell proliferation, and migration 2) . Skin contains about half of the total body hyaluronan 3) . Histological analysis showed that hyaluronan distributes to not only dermis but also epidermis 4) . Furthermore, the ability of keratinocytes to synthesize hyaluronan has been reported in both cell cultures 5, 6) and organ cultures 7, 8) . Pomegranate is a rich source of crude fibers, pectin, sugars, and several tannins 9) . In addition, it has been reported that pomegranate contains some species of flavonoids and anthocyanidins in their seed oil and juice, and shows an antioxidant activity three times more potently than red wine and green tea extract 10, 11) . Furthermore, the chemopreventive and adjuvant therapeutic applications of pomegranate to human breast cancer have been warranted recently 12) . Owing to these significant biological activities, pomegranate juice is being increasingly popularized in world wide. Especially, we already reported that favorable in vivo and in vitro skin protective effects of pomegranate concentrated solution (PCS) including possible in vitro skin moisturizing effects 13, 14) . In addition, PCS and dried pomegranate concentrate powder (PCP) increased the skin hyaluronan contents through up regulated hyaluronan synthase (Has) 1, 2 and 3, and showed related skin moisturizing effects 15) . However, it also pointed out that more detail mechanism studies and in vivo evidences for skin moisturizing effects of PCP and PCS should be further evaluated.
Hyaluronan is synthesized at the inner surface of the plasma membranes as long chains by adding sugar residues at the reducing end, and then is extruded to the extracellular space 16, 17) . The hyaluronan synthase activity has been found to localize exclusively in plasma-membrane fractions of cultured human skin fibroblasts 18, 19) . The synthesis of hyaluronan is stimulated by growth regulatory factors, such as TGF-β1, platelet-derived growth factor-BB, fibroblast growth factor, and epidermal growth factor [20] [21] [22] . Furthermore, it also reported that TGF-β up regulated the Has 1 and 2 1) . In addition, ceramides play a key role in maintaining the structural integrity of the epidermal barrier and epidermal hydration 23, 24) . In this study, therefore, ceramide and TGF-β1 contents with TGF-β1 mRNA expressions were analysis on the skin tissue homogenate samples, collected at our previous study 15) to solve skin moisturizing action mechanism issues of PCS and PCP, at least partially.
Materials and methods

Test materials and animal experiments
Animals, test materials -pomegranate concentrated solution (PCS) and dried pomegranate concentrate powder (PCP), and tissue homogenate were used as same as our previous study 15) . Briefly, total 77 healthy male ICR mice (6-week old upon receipt) were prepared, and ten mice in each group were selected based on the body weight deviations after 7 days of acclimatization. Each of three different dosages of PCP and PCS were orally administered, once a day for 56 days, respectively. PCP was dissolved as 40, 20 and 10 mg/ml in distilled water, and orally administered in a volume of 10 ml/kg, equivalence to 400, 200 and 100 mg/kg of body weights, respectively. PCS was diluted by distilled water as 4:6, 2:8 and 1:9 (v/v) and orally administered in a volume of 10 ml/kg as equivalence to 4, 2 and 1 ml/kg, respectively. Some parts of the hair clipped dorsal skin tissues were separated, individually at 24 hrs after end of last 56th 
Ceramide content measurement
Ceramide concentrations on the skin tissue homogenates were determined using a Quick Start™ Bradford Protein Assay Kit (BioRad, Hercules, CA, USA) and primary antibody coated plate excluded blank ELISA kit (MyBioSource, San Diego, CA, USA). A 96-well plate was coated with 10 μg/well homogenates and incubated overnight at 4 °C. After washing, the wells were blocked with 200 μl/well assay diluent, and incubated with monoclonal anti-ceramide antibody (Sigma-Aldrich, St. Louise, MO, USA; dilution 1:10) for 2 hrs at room temperature. The wells were aspirated, washed three times, and incubated with horseradish-peroxidase -conjugated secondary antibody (100 μl) for 1 hr at 37 °C. 3,3',5,5'-Tetramethylbenzidine substrate (90 μl) was added to each well and incubated for 30 min at 37 °C. Stop solution (50 μl) was added to each well, and the absorbance at 450 nm was measured using a microplate reader (Model Sunrise, Tecan, Männedorf, Switzerland), and skin tissue homogenate levels were calculated from standard ceramide (Sigma-Aldrich, St. Louise, MO, USA) calibration curves as μg/mg protein, according to previous established method 24) with some modifications.
TGF-β1 content measurement
Skin tissue homogenate concentrations of TGF-β 1 were measured using a commercial mouse TGF-β 1 ELISA kit (MyBioSource, San Diego, CA, USA), as pg/mg protein, according to the manufacturer's instructions. Briefly, standards and samples (100 μl) were added to the appropriate wells and incubated for 2 hrs at 37 °C. The wells were aspirated and biotin-labeled antibody (100 μl) was added to each well and incubated for 1 hr at 37 °C. The wells were aspirated, washed three times, and incubated with horseradish peroxidase-conjugated avidin (100 μl) for 1 hr at 37 °C. 3,3',5,5'-Tetramethylbenzidine substrate (90 μl) was added to each well and incubated for 30 min at 37 °C. Stop solution (50 μ l) was added to each well, and the absorbance at 450 nm was measured using a microplate reader 25) .
Realtime RT-PCR
Total RNA in the individual hair clipped dorsal back skins prepared at our previous study 15) , was extracted using Trizol reagent (Invitrogen, Carlsbad, CA, USA), according to the method described in previous studies 26, 27) . The RNA concentrations and quality were determined by CFX96 TM Real-Time System (Bio-Rad, Hercules, CA, USA). To remove contaminating DNA, samples were treated with recombinant DNase I (Ambion, Austin, TX, USA). RNA was reverse transcribed using the reagent High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's instructions. Briefly, the cDNA strand first was synthesized from the total RNA and then the mixture of the primers and the cDNA products was amplified by PCR, and the 
Statistical analysis
All values are expressed as mean ± SD of ten mice in this experiment. Multiple comparison tests for different dose groups were conducted. Variance homogeneity was examined using the Levene test. If the Levene test indicated no significant deviations from variance homogeneity, the obtain data were analyzed by one way ANOVA test followed by least-significant differences (LSD) multi-comparison test to determine which pairs of group comparison were significantly different. In case of significant deviations from variance homogeneity were observed at Levene test, a non-parametric comparison test, Kruskal-Wallis H test was conducted. When a significant difference is observed in the Kruskal -Wallis H test, the Mann-Whitney U (MW) test with Bonferroni's correction was conducted to determine the specific pairs of group comparison, which are significantly different. Statistical analyses were conducted using SPSS for Windows (Release 14.0K, SPSS Inc., Chicago, IL, USA). Differences were considered significant at P < 0.05. In addition, the percent changes between intact vehicle control and test substance administered mice were calculated to help the understanding of the effects of PCP or PCS as [((Data of test material treated mice -Data of intact vehicle control mice)/Data of intact vehicle control mice) × 100], according to our previous report 28) .
Results
Skin ceramide content changes
No significant changes on the skin ceramide contents were observed in PCS 4, 2 and 1 ml/kg, PCP 400, 200 and 100 mg/kg treated mice as compared to those of intact vehicle control mice, at 24 hrs after end of last 56th administration (Fig. 1) . The skin ceramide contents at 24 hrs after end of 56 days of continuous treatment in PCS 4, 2 and 1 ml/kg, PCP 400, 200 and 100 mg/kg treated mice were changed as -1.39, 3.69, -2.33, -2.07, 2.49 and 0.58% as compared with intact vehicle control mice, respectively. 
Skin TGF-β1 content changes
vehicle control mice, at 24 hrs after end of last 56th administration (Fig. 2) . The skin TGF-β1 contents at 24 hrs after end of 56 days of continuous treatment in PCS 4, 2 and 1 ml/kg, PCP 400, 200 and 100 mg/kg treated mice were changed as 35 
Changes on the skin TGF-β1 mRNA expressions
Significant (p<0.01) and dose-dependent increases of skin TGF-β1 mRNA expressions were demonstrated in PCS 4, 2 and 1 ml/kg, PCP 400, 200 and 100 mg/kg treated mouse hair clipped dorsal back skin tissue homogenates as compared with intact vehicle control mice, at 24 hrs after end of last 56th administration (Fig. 3) . The skin TGF-β 1 contents at 24 hrs after end of 56 days of continuous treatment in PCS 4, 2 and 1 ml/kg, PCP 400, 200 and 100 mg/kg treated mice were changed as 46. 19, 32.54, 18.89, 69.24, 47.28 and 35 .81% as compared with intact vehicle control mice, (444) respectively.
Discussion
Various functional skin protective agents have been developed for anti-aging, whitening, wrinkle free, moisturizing and skin protective purposes in market 29, 30) . Currently available functional skin protective agents for skin aging, however, have a number of limitations, such as economic problems, too expensive and exact or detail pharmacological and side effects are not fully understand 15, 31) . Due to these factors, various efforts continuously attempt to search for affordable and effective functional ingredients with fewer side effects, especially on natural antioxidants [13] [14] [15] 30) . In this study, ceramide and TGF-β1 contents with TGF-β1 mRNA expressions were analysis on the skin tissue homogenate samples after 56 days of continuous oral administration of PCS 1, 2, and 4 ml/kg, and PCP 100, 200 and 400 mg/kg, collected at our previous study 15) to solve skin moisturizing action mechanism issues of PCS and PCP, at least partially. As results, noticeable and dose-dependent increases of skin TGF-β1 contents and mRNA expressions were demonstrated in all PCP and PCS treated mice as compared with intact vehicle control, but no significant changes on the skin ceramide contents were demonstrated in all PCP and PCS treated mice as compared with intact vehicle control, in the current study. In addition, PCP 200 mg/kg showed similar increases of the skin TGF-β1 contents and mRNA expressions as compared to those of PCS 4 ml/kg, at least in a condition of the present experiment.
As a bioactive lipid, ceramide has been implicated in a variety of physiological functions including apoptosis, cell growth arrest, differentiation, cell senescence, cell migration and adhesion 32) . Roles for ceramide and its downstream metabolites have also been suggested in a number of pathological states including cancer, neurodegeneration, diabetes, microbial pathogenesis, obesity, and inflammation 33, 34) . Ceramides play a key role in maintaining the structural integrity of the epidermal barrier and epidermal hydration 23, 24) . No significant changes on the skin ceramide contents were demonstrated in all PCP and PCS treated mice as compared with intact vehicle control, suggesting oral administration of PCP and PCS did not influenced on the skin ceramide contents, and skin moisturizing effects PCP and PCS oral administration, detected in our previous study 15) may be mediated through hyaluronan rather than ceramide, at least in a condition of the current analysis.
Hyaluronan, a major extracellular matrix component of the skin with collagen, plays important roles in skin physiology including water homeostasis 13, 27, 35) , and synthesis by Has 1, Has 2 and Has 3 27, 36, 37) . TGF-β plays a key role through regulating different cellular functions, and enhancing granulation tissue formation and collagen formation 38) . In addition, TGF-β has also been reported to be able to promote wound contraction through its direct induction of alpha smooth muscle act in expression in fibroblasts 39, 40) . The synthesis of hyaluronan is stimulated by growth TGF-β1 [20] [21] [22] , and TGF-β up regulated the Has 1 and 2 1) . In the present analysis, noticeable and dose-dependent increases of skin TGF-β1 contents and mRNA expressions were demonstrated in all PCP and PCS treated mice as compared with intact vehicle control, and PCP 200 mg/kg showed similar increases of the skin TGF-β1 contents and mRNA expressions as compared to those of PCS 4 ml/kg. These findings are considered as direct evidences that in vivo skin moisturizing effects of PCP and PCS after oral administration through up regulation of hyaluronan synthesis demonstrated in our previous results 15) , may be possibly mediated by modulation of TGF-β1 expressions at least partially, in a condition of the present skin tissue homogenate analysis 7 (445) 
